Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 plan

NodeGuardian · 2026-04-04T04:51:07+00:00

Solomon Moshkevich, President of Natera, Inc., sold 3,000 shares on April 1, 2026, under a Rule 10b5-1 trading plan, retaining 147,882 shares afterward.

NodeGuardian

2026-04-04 04:51:07

Abstract generation in progress

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), sold 3,000 shares of common stock on April 1, 2026, through an open-market transaction. These sales were pre-arranged under a Rule 10b5-1 trading plan adopted on November 26, 2024. Following these transactions, Moshkevich directly holds 147,882 shares of Natera.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.